logo_web
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
✕
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet

AstraZeneca Foundation encourages young talent with 80,000 euros

Source: redaccionmedica.com

The AstraZeneca Foundation, in collaboration with the Carlos III Health Institute, has announced the winners of the IV Young Researchers Awards, a recognition that drives the scientific career of researchers under 40 years of age. In this fourth edition, the winners are Gabriel Sanfélix-Gimeno in the category of Acute Coronary Syndrome, Guadalupe Sabio in Type II Diabetes and Obesity, Arkaitz Carracedo in Oncology and Astrid Crespo in the area of ??Asthma and Chronic Obstructive Pulmonary Disease.

The winners will receive a grant of 20,000 euros each so that they can continue to develop leading-edge research in diseases that affect millions of patients. As part of the recognition, the winners will have the opportunity to visit the centers of AstraZenecacorresponding to their field of research and to meet with those responsible for scientific talent of the company.
“With the Young Researchers Awards of the AstraZeneca Foundation we want to give the opportunities that scientists deserve. The winners have shown that their research is innovative and has a clinical potential that must be supported. They have the curiosity, talent and passion that, with the support of public and private institutions, will be able to mark a before and after in the lives of patients, “said Eduardo Recoder, president of the AstraZeneca Foundation.

The works of the winners
In the Acute Coronary Syndrome category, the prizewinner was Gabriel Sanfélix-Gimeno, from the Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO) for his research “Treatment at discharge, adherence and clinical results after acute coronary syndrome. . Population cohort with up to 10 years of follow-up “.

Guadalupe Sabio Buzo, from the National Center for Cardiovascular Research (CNIC) in Madrid, has won the prize in the Type II Diabetes and Obesity category for her work “The role of p38MAPK in the development of obesity and associated diseases”.

In the third place, Arkaitz Carracedo, of the Association for Cooperative Research in Biosciences (CIC bioGUNE) in Vizcaya, has been awarded the fellowship in the Oncology category, personalized therapy and immunotherapy for his research “New avenues in the treatment of cancer aggressive breast by manipulating the metabolism. ”

Finally, in the category of Asthma and Chronic Obstructive Disease, Astrid Crespo, of the Hospital of Santa Creu i Sant Pau has been awarded for her work entitled “Neutrophilic Asthma Not Eosinophilic (ANNE)”.
Trajectory dedicated to patients
Along with the recognition of young talents, the AstraZeneca Foundation has awarded the Honorary Award for Excellence in Scientific Trajectory to Miguel Martín Jiménez, head of the Oncology Service at the Gregorio Marañón General University Hospital in Madrid, for devoting his entire career to the advancement of scientific knowledge in the field of medical oncology. Martin will receive 5,000 euros that will go to the institution and the research project he chooses.

Award ceremony IV Young Researchers Awards
The awards are framed in the ‘IV Youth and Science Conference: Promoting Scientific Talent’ and will be delivered on September 26 at the Rafael del Pino Auditorium in Madrid at 4:45 p.m. May-Britt Moser, Nobel Prize in Medicine in 2014, will be the main speaker at the event.

 

At Distefar we support this type of initiative that encourages researchers to continue developing their work.

Related entries

9 February, 2026

Artificial intelligence enables more accurate stratification of breast cancer risk


Leer más
5 February, 2026

From potential to results: how pharmaceutical companies measure the impact of AI on their forecasts


Leer más
3 February, 2026

The ‘Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy’, recognized with the Diagnosis Award


Leer más

Recent Posts

  • Artificial intelligence enables more accurate stratification of breast cancer risk
  • From potential to results: how pharmaceutical companies measure the impact of AI on their forecasts
  • The ‘Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy’, recognized with the Diagnosis Award
  • Artificial intelligence accelerates drug development, but has yet to discover the miracle molecule
  • GEPAC and Farmaindustria sign an agreement to promote research, access to innovation, and the measurement of health outcomes in oncology

Contacta con nosotros


Tfno: +34 955.77.67.67
Fax: +34 955.77.65.56
info@distefar.net


Distefar del Sur
Sede Central

Distefar del Sur S.L.
Av. Umbrete, 58,
41110 Bollullos de la Mitación, Sevilla

Sede Madrid

Calle de Zurbano, 45, 28010 Madrid

CENTRAL

Pol. PIBO. Avda. de Gines, 14
+34 955 776 767 /+34 692 454 913
41110 Bollullos de la Mitación (Sevilla)

MADRID DELEGATION

+34 674 575 115
28010 Madrid

Links of interest

  • Legal warning
  • Privacy policy
  • Cookies policy
  • Contact

© 2026 Distefar del Sur SL. All rights reserved. agencianodo.com

  • Contact
  • Private Zone
  • Español
  • English

    [recaptcha]

    In accordance with the provisions of Regulation (EU) 2016/679 and Organic Law 3/2018 regarding Data Protection, we inform you that the data you provide in this form will be incorporated into a file owned by DISTEFAR DEL SUR, SL domiciled in the C / Umbrete 58, (Pol. Ind. Pibo), 41110 of Bollullos de la Mitación (Seville), in order to manage your request.

    In this regard, and if you wish to exercise your rights of access, rectification, cancellation, opposition, portability and limitation, please send a written communication to DISTEFAR DEL SUR, SL, to the address indicated above or to info@distefar.com, attaching copy of your National Identity Document or equivalent identification document.

    Basic information about Data Protection

     Epigraph

    Basic information Data Protection

    Responsable

    DISTEFAR DEL SUR, S.L.

    Purpose

    Process your inquiry / request
    Detailed information on Data Protection

    Legitimation

    Consent
    Detailed information on Data Protection

    Recipients

    It is not expected to carry out data communications to third parties, except legal obligation
    Transfers of data to third countries outside the European Union will not be carried out
    Detailed information on Data Protection

    Rights

    You have the right of access, rectification, deletion, portability of your data, as well as limitation or opposition to your treatment, as detailed in Detailed information on Data Protection

    Additional Information

    You can consult the additional and detailed information on data protection by clicking here Detailed information on Data Protection

    All the data requested / The fields marked with * in the form are mandatory, if not filled in DISTEFAR DEL SUR, S.L. will not be able to meet your request.